Patents by Inventor Chae Jo LIM

Chae Jo LIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Positive electrode active material for lithium secondary battery and lithium secondary battery
    Patent number: 12211997
    Abstract: Provided is a lithium secondary battery which includes a positive electrode, a negative electrode, a separator interposed between the positive electrode and the negative electrode, and an electrolyte, wherein the positive electrode includes a lithium composite transition metal oxide powder having a layered structure and a nickel content accounting for 85 atm % or more of total transition metals, and wherein the lithium composite transition metal oxide powder undergoes a 3% or less change in lithium-oxygen (Li—O) interlayer spacing in a state-of-charge (SOC) range of 58% to 72%.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: January 28, 2025
    Assignee: LG Chem, Ltd.
    Inventors: Hyeon Hui Baek, Sung Ho Ban, Jun Ho Eom, Chae Jin Lim, Sang Jo Lee, Na Ri Park
  • Compounds having PDE9A inhibitory activity, and pharmaceutical uses thereof
    Patent number: 12195469
    Abstract: The present invention provides a compound having a specific chemical structure and having PDE9A inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention provides a composition containing the compound or a pharmaceutically acceptable salt thereof. The present invention provides a pharmaceutical use, for treating or preventing PDE9A-related diseases, of the compound according to the present invention, a salt thereof, and a composition containing the compound or salt. The present invention also provides a method for treating or preventing PDE9A-related diseases, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing the compound or salt to a subject in need of treatment.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: January 14, 2025
    Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Chae Jo Lim, Kwang-Seok Oh, Jeong Hyun Lee, Kyu Yang Yi, Nack Jeong Kim, Byung Ho Lee, Ho Won Seo, Soo Hee Kim, Junyoung Choi, Mi Young Lee, Ju Hee Lee
  • Compounds having PDE9A inhibitory activity, and pharmaceutical uses thereof
    Patent number: 12187729
    Abstract: The present invention provides a compound having a specific chemical structure and having PDE9A inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention provides a composition containing the compound or a pharmaceutically acceptable salt thereof. The present invention provides a pharmaceutical use, for treating or preventing PDE9A-related diseases, of the compound according to the present invention, a salt thereof, and a composition containing the compound or salt. The present invention also provides a method for treating or preventing PDE9A-related diseases, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing the compound or salt to a subject in need of treatment.
    Type: Grant
    Filed: December 5, 2019
    Date of Patent: January 7, 2025
    Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Chae Jo Lim, Kwang-Seok Oh, Jeong Hyun Lee, Kyu Yang Yi, Nack Jeong Kim, Byung Ho Lee, Ho Won Seo, Soo Hee Kim, Junyoung Choi, Mi Young Lee, Ju Hee Lee
  • COMPOUNDS HAVING PDE9A INHIBITORY ACTIVITY, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20220024932
    Abstract: The present invention provides a compound having a specific chemical structure and having PDE9A inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention provides a composition containing the compound or a pharmaceutically acceptable salt thereof. The present invention provides a pharmaceutical use, for treating or preventing PDE9A-related diseases, of the compound according to the present invention, a salt thereof, and a composition containing the compound or salt. The present invention also provides a method for treating or preventing PDE9A-related diseases, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing the compound or salt to a subject in need of treatment.
    Type: Application
    Filed: December 5, 2019
    Publication date: January 27, 2022
    Inventors: Chae Jo LIM, Kwang-Seok OH, Jeong Hyun LEE, Kyu Yang YI, Nack Jeong KIM, Byung Ho LEE, Ho Won SEO, Soo Hee KIM, Junyoung CHOI, Mi Young LEE, Ju Hee LEE
  • COMPOUNDS HAVING PDE9A INHIBITORY ACTIVITY, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20220017528
    Abstract: The present invention provides a compound having a specific chemical structure and having PDE9A inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention provides a composition containing the compound or a pharmaceutically acceptable salt thereof. The present invention provides a pharmaceutical use, for treating or preventing PDE9A-related diseases, of the compound according to the present invention, a salt thereof, and a composition containing the compound or salt. The present invention also provides a method for treating or preventing PDE9A-related diseases, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing the compound or salt to a subject in need of treatment.
    Type: Application
    Filed: December 5, 2019
    Publication date: January 20, 2022
    Inventors: Chae Jo LIM, Kwang-Seok OH, Jeong Hyun LEE, Kyu Yang YI, Nack Jeong KIM, Byung Ho LEE, Ho Won SEO, Soo Hee KIM, Junyoung CHOI, Mi Young LEE, Ju Hee LEE